Eli Lilly and Company (LLY)

342.10 -5.91 (-1.70%)
Close USD Disclaimer
343.22 +1.11 (+0.33%)

Eli Lilly and Company Company Profile

Equity Type
Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Trajenta, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant, Baricitinib, and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab, Cialis, and Forteo. It maintains special business groups to service wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, government and long-term care institutions, hospitals, and certain retail pharmacies. It manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. Its products are sold in about 120 countries.
Contact Information
Indianapolis,46285 United States
317 276 2000
Top Executives
Sidney Taurel 72 1991 Chairman Emeritus
David A. Ricks 53 2012 Chairman, CEO & President
Carolyn R. Bertozzi 54 2017 Independent Director
William G. Kaelin 64 2012 Independent Director
Jackson Peter Tai 72 2013 Independent Director
Juan Ricardo Luciano 61 2016 Lead Independent Director
Jamere Jackson 53 2016 Independent Director
Karen M. Walker 60 2018 Independent Director
Marschall S. Runge 68 2013 Independent Director
Kimberly H. Johnson 49 2021 Independent Director
Ralph Alvarez 67 2009 Independent Director
Katherine Baicker 50 2011 Independent Director
Gabrielle E. Greene-Sulzberger 62 2021 Independent Director
J. Erik Fyrwald 63 2005 Independent Director
Mary Lynne Hedley 59 2022 Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles